AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SYDNEY, May 1 Asia Pulse - Pathology, medical centres and drugs distributor Symbion Health Ltd (ASX:SYB) has received an unsolicited takeover proposal from a private equity consortium valuing the company at $A2.78 billion ($US2.3 billion).
The offer, from a consortium comprising rival Healthscope Ltd, Ironbridge Capital and Archer Capital, is "incomplete and non-binding", Symbion said.
It said talks with the consortium in relation to the offer, which values it at $4.30 per share, are preliminary.
"These discussions are preliminary and incomplete and no agreement has been reached in relation to the proposal," a statement from the company said.
"There is no certainty that agreement will be reached at any future time, or that a formal offer or proposal will be put to Symbion Health shareholders."
The proposal provides for Healthscope to acquire all of Symbion Health shares on issue by way of a scheme of arrangement in exchange for cash and Healthscope shares, valued at ...